Topchoice Medical Co (600763) Fair Value & Analysis
Healthcare · CN · Market cap 16.4B CNY
Fair value as of: Aug 9, 2026
From 26 valuation models · updated yesterday
Share price +8.2% over the past month.
A solid business, but screening 33% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥30.86). The favourable scenario is already priced in.
- Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 9, 2026.
How to read this chart
60‑month range ¥33.33 – ¥298.44 · fair‑value band ¥18.52 – ¥30.86 · the ¥36.62 price screens above the ¥24.69 fair value. Dashed = 300-day average. As of Aug 9, 2026.
Analysis
Topchoice Medical Co (600763) currently trades at ¥36.62, while our model-based Fair Value estimate is ¥24.69, implying the stock looks roughly 32.6% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Topchoice Medical Co generated revenue of 2.9B CNY at a net margin of 17.3%. Revenue grew 1.4% year over year. It earns a return on equity of 12.7%. Net debt stands at 694M CNY. Fundamentals as of Aug 9, 2026
Our scenario range runs from ¥18.52 (bear case) to ¥30.86 (bull case); at ¥36.62, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -33%, 600763 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (¥52.14) versus Asset-Based (¥6.34). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 62 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Topchoice Medical Co., Inc. offers oral medical services in China. The company is involved in the sale of medical equipment, daily necessities, disinfection products, investment management, import and export business, technology development, technology consulting and technology services, and training services, as well as offers dental medical services.
Full company description
Topchoice Medical Co., Inc. offers oral medical services in China. The company is involved in the sale of medical equipment, daily necessities, disinfection products, investment management, import and export business, technology development, technology consulting and technology services, and training services, as well as offers dental medical services. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Co., Inc. in November 2019. Topchoice Medical Co., Inc. was incorporated in 1995 and is based in Hangzhou, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Topchoice Medical Co reported revenue of ¥2.9B in FY2025 versus ¥2.8B in FY2021, a compound +1.2%/yr. Reported net income was ¥502M in FY2025, compounding −8.1%/yr from FY2021.
600763 screens 33% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Topchoice Medical Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Topchoice Medical Co (600763) overvalued or undervalued?
What is the fair value of 600763?
What is the quality score of 600763?
What is the revenue of Topchoice Medical Co (600763)?
What is the net profit margin of 600763?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Topchoice Medical Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.